Acrospire Investment Management LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 181 filers reported holding HAEMONETICS CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Acrospire Investment Management LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2017$51,000
-16.4%
1,300
-13.3%
0.05%
-4.0%
Q1 2017$61,000
-68.4%
1,500
-68.8%
0.05%
-36.7%
Q4 2016$193,000
+56.9%
4,800
+41.2%
0.08%
-3.7%
Q3 2016$123,000
+192.9%
3,400
+183.3%
0.08%
+182.8%
Q1 2016$42,0001,2000.03%
Other shareholders
HAEMONETICS CORP shareholders Q3 2016
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders